Bing Xie
ORCID: 0000-0002-1692-7199Also affiliated with Illinois Institute of Technology, Chinese Academy of Medical Sciences & Peking Union Medical College, Shenzhen Weiguang Biological Products (China)
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 10 papers. Top paper: “Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor”.
Caroline A. Cuoco, Bing Xie, Yoon Namkung, Varun V. Prabhu, Blair K. A. Willette +8 more
Bing Xie, Ana Semeano, Alessandro Bonifazi, Francisco O. Battiti, Amy Hauck Newman +3 more
Alexander Holenstein, William R. Foster, Bing Xie, Kevin B. Hicks, Céline Bürer +12 more
Alexander A. Goldberg, Lei Shi, Bing Xie
Daniel S. Terry, G. Glenn Gregorio, Alem W. Kahsai, Alessandro Borgia, Bing Xie +13 more
Alexander Goldberg, Lei Shi, Bing Xie
Agnieszka Sulima, Dan Luo, Thomas E. Prisinzano, Alexander Goldberg, Bing Xie +9 more
Valerie P. Le Rouzic, Alexander Goldberg, Meng-Hua M. Tsai, Li Chen, Tiffany Zhang +5 more
Bing Xie, Lei Shi, Alexander Goldberg
Bing Xie, Lei Shi, Alexander Goldberg